zolpidem has been researched along with Brain Neoplasms in 3 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Zolpidem is a nonbenzodiazepine hypnotic used to treat insomnia that has also been observed to paradoxically improve arousal in those with DOC, such as the vegetative or minimally conscious states." | 4.95 | Improved Arousal and Motor Function Using Zolpidem in a Patient With Space-Occupying Intracranial Lesions: A Case Report. ( Bomalaski, MN; Smith, SR, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harnod, T | 1 |
| Li, YF | 1 |
| Lin, CL | 1 |
| Chang, SN | 1 |
| Sung, FC | 1 |
| Kao, CH | 1 |
| Bomalaski, MN | 1 |
| Smith, SR | 1 |
| Irvin, W | 1 |
| MacDonald, G | 1 |
| Smith, JK | 1 |
| Kim, WY | 1 |
1 review available for zolpidem and Brain Neoplasms
| Article | Year |
|---|---|
Improved Arousal and Motor Function Using Zolpidem in a Patient With Space-Occupying Intracranial Lesions: A Case Report.
Topics: Arousal; Brain Neoplasms; Consciousness Disorders; Follow-Up Studies; GABA-A Receptor Agonists; Huma | 2017 |
2 other studies available for zolpidem and Brain Neoplasms
| Article | Year |
|---|---|
Higher-dose uses of zolpidem will increase the subsequent risk of developing benign brain tumors.
Topics: Adult; Age Distribution; Aged; Anxiety; Brain Neoplasms; Cohort Studies; Female; GABA-A Receptor Ago | 2015 |
Dexamethasone-induced posterior reversible encephalopathy syndrome.
Topics: Anti-Inflammatory Agents; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Dexamethasone; Dopamine A | 2007 |